ENTITY

International Stem Cell (ISCO US)

7
Analysis
Health CareUnited States
International Stem Cell Corporation develops therapeutic and research products in the biotechnology industry. The Company seeks to use human cells for use in the treatment of several diseases including diabetes, as well as in liver and retinal diseases.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x